KY-1006

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameKY-1006

Drug Alias NameKY-1006

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 14

TargetsTumor necrosis factor superfamily member 14

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKymab Ltd

China Registration ClassN/A

Active CompaniesKymab Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A